J 2005

Efficacy, Safety And Tolerability Of Metoprolol Cr/Xl In Diabetic Patients With Chronic Heart Failure

DEEDWANIA, Prakash, Jindřich ŠPINAR, Jiří VÍTOVEC, Thomas GILES, Michael KLINBAUER et. al.

Basic information

Original name

Efficacy, Safety And Tolerability Of Metoprolol Cr/Xl In Diabetic Patients With Chronic Heart Failure

Name in Czech

Učinnost, bezpečnost a snášenlivost metoprololu u diabetiků se srdečním selháním

Name (in English)

Efficacy, Safety And Tolerability Of Metoprolol Cr/Xl In Diabetic Patients With Chronic Heart Failure

Authors

DEEDWANIA, Prakash (840 United States of America), Jindřich ŠPINAR (203 Czech Republic), Jiří VÍTOVEC (203 Czech Republic, guarantor), Thomas GILES (840 United States of America) and Michael KLINBAUER (840 United States of America)

Edition

Amirican Heart Journal, St.Luis, Mosby, 2005, 0002-8703

Other information

Language

Czech

Type of outcome

Článek v odborném periodiku

Field of Study

30201 Cardiac and Cardiovascular systems

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 3.552

RIV identification code

RIV/00216224:14110/05:00014897

Organization unit

Faculty of Medicine

UT WoS

000226387000024

Keywords in English

Heart failure; diabetes mellitus;metoprolol CR/XL
Změněno: 9/2/2006 08:26, prof. MUDr. Jiří Vítovec, CSc.

Abstract

V originále

Efficacy, Safety And Tolerability Of Metoprolol Cr/Xl In Diabetic Patients With Chronic Heart Failure Experience from the MERIT-HF Trial

In English

Efficacy, Safety And Tolerability Of Metoprolol Cr/Xl In Diabetic Patients With Chronic Heart Failure Experience from the MERIT-HF Trial

Links

MSM0021622402, plan (intention)
Name: Časná diagnostika a léčba kardiovaskulárních chorob
Investor: Ministry of Education, Youth and Sports of the CR, Early diagnostics and treatment of cardiovascular diseases